Vnitr Lek 2019, 65(3):187-192 | DOI: 10.36290/vnl.2019.035

Intravenous fluid therapy in acutely ill patients for non-intensivists

Martin Matějovič1,2,*, Jan Horák1,2, Martin Harazim1,2, Thomas Karvunidis1,2, Jaroslav Raděj1,2, Ivan Novák1
1 I. interní klinika LF UK a FN Plzeň
2 Biomedicínské centrum LF UK, Plzeň

Intravenous fluid therapy is the most frequent therapeutic intervention in acutely hospitalized patients. They are administered in order to resuscitate the circulation in hypovolemia-associated shock states, to compensate for an impending or existing fluid extracellular deficit, or as a maintenance infusion if the patient is incapable of taking fluid by other means. Any fluid should be prescribed with the same caution as with any other drug. Errors in fluid therapy adversely affect patient - centered outcome. This may be the result of an incorrectly selected amount or inappropriate fluid composition for a given clinical situation. Prescribing intravenous fluids is a complex process involving a decision on the type, composition, dose, rate and possible toxicity of the particular solution. Balanced crystalloid solutions are the first choice for most acute conditions. The need for fluids dynamically changes over time in acutely ill patients. Uncontrolled cumulative positive balance is associated with substantial morbidity and mortality.

Keywords: colloids; crystalloids; fluid resuscitation; fluid therapy

Received: June 28, 2018; Accepted: January 28, 2019; Published: March 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Matějovič M, Horák J, Harazim M, Karvunidis T, Raděj J, Novák I. Intravenous fluid therapy in acutely ill patients for non-intensivists. Vnitr Lek. 2019;65(3):187-192. doi: 10.36290/vnl.2019.035.
Download citation

References

  1. Kellum JA. Abnormal saline and the history of intravenous fluids. Nat Rev Nephrol 2018; 14(6): 358-360. Dostupné z DOI: <http://dx.doi.org/10.1038/s41581-018-0008-4>. Go to original source... Go to PubMed...
  2. Glassford NJ, Bellomo R. Does Fluid Type and Amount Affect Kidney Function in Critical Illness? Crit Care Clin 2018; 34(2): 279-298. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ccc.2017.12.006>. Go to original source... Go to PubMed...
  3. Semler MW, Self WH, Wanderer JP et al. [SMART Investigators and the Pragmatic Critical Care Research Group]. Balanced Crystalloids versus Saline in Critically Ill Adults. N Engl J Med 2018; 378(9): 829-839. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1711584>. Go to original source... Go to PubMed...
  4. Self WH, Semler MW, Wanderer JP et al. [SALT-ED Investigators]. Balanced Crystalloids versus Saline in Noncritically Ill Adults. N Engl J Med 2018; 378(9): 819-828. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1711586>. Go to original source... Go to PubMed...
  5. Morgan TJ. The ideal crystalloid - what is 'balanced'? Curr Opin Crit Care 2013; 19(4): 299-307. Dostupné z DOI: <http://dx.doi.org/10.1097/MCC.0b013e3283632d46>. Go to original source... Go to PubMed...
  6. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med 2013; 369(13): 1243-1251. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMra1208627>. Go to original source... Go to PubMed...
  7. Rochwerg B, Alhazzani W, Gibson A et al. [FISSH Group (Fluids in Sepsis and Septic Shock)]. Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis. Intensive Care Med 2015; 41(9): 1561-1571. Dostupné z DOI: <http://dx.doi.org/10.1007/s00134-015-3794-1>. Go to original source... Go to PubMed...
  8. Moeller C, Fleischmann C, Thomas-Rueddel D et al. How safe is gelatin? A systematic review and meta-analysis of gelatin-containing plasma expanders vs crystalloids and albumin. J Crit Care 2016; 35: 75-83. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jcrc.2016.04.011>. Go to original source... Go to PubMed...
  9. Moritz ML, Ayus JC. Maintenance Intravenous Fluids in Acutely Ill Patients. N Engl J Med 2015; 373(14): 1350-1360. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMra1412877>. Go to original source... Go to PubMed...
  10. Weinberg L, Harris L, Bellomo R et al. Effects of intraoperative and early postoperative normal saline or Plasma-Lyte 148® on hyperkalaemia in deceased donor renal transplantation: a double-blind randomized trial. Br J Anaesth 2017; 119(4): 606-615. Dostupné z DOI: <http://dx.doi.org/10.1093/bja/aex163>. Go to original source... Go to PubMed...
  11. Prowle JR, Kirwan CJ, Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol 2014; 10(1): 37-47. Dostupné z DOI: <http://dx.doi.org/10.1038/nrneph.2013.232>. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.